GENE EXP. AND GENOTYPING

基因实验。

• 批准号: 7529366
• 负责人: MARTINA L VEIGL
• 金额: $ 22.54万
• 依托单位: CASE WESTERN RESERVE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-07-06 至 2012-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7529366
• 关键词: Address; Area; Award; Biological Assay; Cancer Center; Chemistry; Clinic; Communities; Computers; Consult; Consultations; Custom; Data; Detection; Equipment; Foundations; Gene Expression; Generations; Genes; Genotype; Grant; Growth; Hospitals; Laboratories; Liquid substance; Maps; Mission; Movement; Nucleic Acids; Numbers; Play; Polymerase Chain Reaction; Preparation; Process; Reader; Research; Research Personnel; Resources; Robotics; Role; Sampling; Secure; Services; Staging; System; Technology; Time; Universities; University Hospitals; Work; base; day; density; design; discount; genetic technology; genome wide association study; genotyping technology; member; programs; size

The mission of the Gene Expression and Genotyping Facility (GEGF) is to facilitate implementation of high throughput genetic technologies for the research conducted by members of the Case community. The GEGF serves as a technical and consulting resource for Cancer Center members, as well as other investigators who have laboratories at Case Western Reserve University, University Hospitals of Cleveland, the Cleveland Clinic Foundation, the VA Hospital, and MetroHealth Hospital in the areas of high throughput expression analysis and genotyping. It is the only facility of its capability in Cleveland. This facility utilizes Affymetrix and Applied Biosystems (ABI) technologies to provide global and quantitative (on user-identified genes) gene expression analysis services. A diverse array of Affymetrix and ABI technologies are available to address a spectrum of genotyping needs, including whole genome scans, custom designed fine-mapping studies involving 3,000-10,000 SNPs and interrogation of small numbers (<100) of specific SNPs in thousands of samples. The core operates in a full-service mode with staff providing initial consultation, executing the chemistry, carrying out the analysis, and offering data trimming and data interpretation services. To carry out these technologies, the GEGF has 14 computers, an Affymetrix Workstation dedicated to data generation, 3 fluidics stations, 2 hybridization ovens and a GC3000 scanner with autoloader. ABI equipment includes a 7,900 Sequence Detection System, with a barcode reader, robotics allowing the capability to process 5,000 sample wells per day, and the modules for processing Low Density Arrays, 96- and 384-well plates. The GEGF also has 5 GeneAMP ABI 9700 PCR machines, with 96- & 384-well block capability and an ABI 6100 Nucleic Acid Prep Station. For PCR-based assays, the GEGF established an amplicon-free room, containing 2 PCR hoods, dedicated pipettors, small microfuges and minithermocyclers. Additional equipment includes: 2 Matrix robotic liquid handling systems, the PlateMate 2x2 (X-Y stage movement) and the PlateMate Plus (allows rapid reconfiguration from 96- to 384-well format), dedicated centrifuges, an Agilent Bioanalyzer and a NanoDrop Spectrophotometer, which quantifies nucleic acids in 1-2 ul samples. Turn-around time for sample preparation and analysis is <10 days for average size projects and satisfactory timetables are established for large projects during initial consultations. Cancer Center members receive a 35% discount on all GEGF provided services. The core has steadily grown from its inception in 2000, when we had 22 users and a single full-time staff member to its current staff of 51/2 and 142 registered users. Approximately 60 investigators use the GEGF every year and 30-50% of these are first time users, documenting that the GEGF continues to enjoy a healthy level of growth and a robust level of sustained work with repeat users. Finally, the GEGF has provided services for members from 8 of the Cancer Center's programs, and has played a role in securing more than 33 grants awarded to Cancer Center members.

基因表达和基因分型设施（GEGF）的使命是促进实施高水平的 为凯斯社区成员进行的研究提供高通量遗传技术。GEGF 作为癌症中心成员以及其他研究人员的技术和咨询资源， 在凯斯西储大学、克利夫兰大学医院、克利夫兰诊所都有实验室 基金会、VA医院和MetroHealth医院在高通量表达分析和 基因分型这是克利夫兰唯一的设施。该机构利用Affyoung和Applied 生物系统（ABI）技术提供全球和定量（用户识别的基因）基因表达 分析服务。各种Affyandroid和ABI技术可用于解决一系列 基因分型需求，包括全基因组扫描，定制设计的精细定位研究，涉及3000 - 10000 SNP和在数千个样品中的少量（<100）特定SNP的询问。核心在 全方位服务模式，由工作人员提供初步咨询，执行化学分析，以及 提供数据整理和数据解释服务。为了实现这些技术，GEGF有14个 计算机，一个专用于数据生成的Affyphon工作站，3个流体站，2个杂交炉， GC 3000扫描仪和自动加载器ABI设备包括一个7，900序列检测系统，带有条形码 读取器，机器人，允许每天处理5，000个样品威尔斯，以及处理模块 低密度阵列，96孔和384孔板。GEGF还拥有5台GeneAMP ABI 9700 PCR仪， 和384孔块能力和ABI 6100核酸制备站。对于基于PCR的测定，GEGF 建立了一个无扩增子室，包含2个PCR罩、专用移液器、小型微量离心器和微型热循环仪。 其他设备包括：2台Matrix机器人液体处理系统，PlateMate 2x2（X-Y 平台移动）和PlateMate Plus（允许从96孔到384孔格式的快速重新配置），专用 离心机、Agilent生物分析仪和NanoDrop分光光度计，其定量1-2 μ l中的核酸 样品对于一般规模的项目，样品制备和分析的周转时间小于10天， 在初步磋商期间，为大型项目制定了令人满意的时间表。癌症中心成员 享受GEGF提供的所有服务的35%折扣。核心从2000年成立以来一直稳步增长， 当时我们有22个用户和一个全职工作人员，而目前的工作人员为51/2和142个注册用户。 每年大约有60名研究人员使用GEGF，其中30-50%是第一次使用， GEGF继续享有健康的增长水平和与重复用户的持续工作的强劲水平。 最后，GEGF已经为癌症中心的8个项目的成员提供了服务，并发挥了 在确保超过33个赠款授予癌症中心成员的作用。